Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
-
Source:
Radioembolization for HCC Patients With Personalized Yttrium-90 Dosimetry for Curative Intent (RAPY90D)
تفاصيل العنوان
-
Source:
Yttrium-90 Radioembolization for Cirrhosis-Associated Thrombocytopenia
تفاصيل العنوان
-
Source:
RENEGADE: Radioembolization for Early Stage Renal Cell Carcinoma: An Open-Label, Prospective, Multi-Center, Phase 1/2 Safety Trial
تفاصيل العنوان
-
Source:
A Phase 2 Trial of Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy (aTac-BEAM) Conditioning for Autologous Hematopoietic Cell
تفاصيل العنوان
-
Source:
Clinical Outcomes and Quality of Life After Transarterial Radioembolization With Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors
تفاصيل العنوان
-
Source:
Pilot Study of Nivolumab in Combination With Therasphere (Yttrium-90) for Treatment of Hepatocellular Carcinoma (HCC) With Intent for Resection
تفاصيل العنوان
-
Authors :
Michael V Knopp MD PhD, Principal Investigator
-
Source:
PET/CT-Derived Hepatopulmonary Shunt Fraction Following Yttrium-90 Radioembolization
تفاصيل العنوان
-
Source:
A Phase II Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Undergoing Liver-directed Radioembolization With Yttrium-90
تفاصيل العنوان
-
Authors :
Gao-jun Teng, Dean
-
Source:
Yttrium-90 Carbon Microspheres in Patients With Unresectable Hepatocellular Carcinoma: A Multicentre, Prospective, Open-label, Single-arm Trial
تفاصيل العنوان
-
Authors :
Gao-jun Teng, Dean
-
Source:
Yttrium-90 Carbon Microspheres in Patients With Unresectable Colorectal Liver Metastases: A Multicentre, Prospective, Open-label, Single-arm Trial
تفاصيل العنوان
